We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF

215 hedge funds and large institutions have $482M invested in ARK Genomic Revolution ETF in 2025 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 54 increasing their positions, 56 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more call options, than puts

Call options by funds: $109M | Put options by funds: $96.5M

1.15% more ownership

Funds ownership: 52.03%53.18% (+1.1%)

4% less repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 56

10% less funds holding

Funds holding: 239215 (-24)

16% less capital invested

Capital invested by funds: $575M → $482M (-$92.6M)

43% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 42

Holders
215
Holders Change
-24
Holders Change %
-10.04%
% of All Funds
2.88%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
24
Increased
54
Reduced
56
Closed
42
Calls
$109M
Puts
$96.5M
Net Calls
+$12.7M
Net Calls Change
-$6.93M
Name Holding Trade Value Shares
Change
Change in
Stake
CAM
26
Cresset Asset Management
Illinois
$1.49M +$1.3M +51,636 +257%
Balyasny Asset Management
27
Balyasny Asset Management
Illinois
$1.47M -$804K -31,998 -31%
Envestnet Asset Management
28
Envestnet Asset Management
Illinois
$1.46M -$59.8K -2,380 -3%
BPA
29
Beacon Pointe Advisors
California
$1.42M +$1.72M +68,439 New
Squarepoint
30
Squarepoint
New York
$1.42M +$1.5M +59,781 +692%
EWM
31
Elmwood Wealth Management
California
$1.36M +$83.2K +3,312 +5%
IMC Chicago
32
IMC Chicago
Illinois
$1.3M +$401K +15,972 +34%
WP
33
Woodline Partners
California
$1.29M -$424K -16,862 -21%
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
$1.17M -$1.01M -40,170 -42%
BCM
35
Brookstone Capital Management
Illinois
$1.15M -$79.4K -3,161 -5%
Jane Street
36
Jane Street
New York
$992K -$7.28M -289,801 -86%
Credit Agricole
37
Credit Agricole
France
$970K +$500K +19,894 +74%
Mariner
38
Mariner
Kansas
$967K +$1.03K +41 +0.1%
Stifel Financial
39
Stifel Financial
Missouri
$951K -$11.2K -446 -1%
Wealthfront Advisers
40
Wealthfront Advisers
California
$945K +$57.2K +2,277 +5%
SB
41
SIG Brokerage
New York
$901K +$72.9K +2,900 +7%
AAS
42
Ameritas Advisory Services
Nebraska
$886K +$59.2K +2,357 +6%
Baird Financial Group
43
Baird Financial Group
Wisconsin
$825K +$744K +29,629 +293%
Carson Wealth (CWM LLC)
44
Carson Wealth (CWM LLC)
Nebraska
$792K +$94.9K +3,777 +11%
B
45
Bellecapital
Switzerland
$789K -$6.83K -272 -0.7%
PFS
46
Prospera Financial Services
Texas
$767K +$31.5K +1,253 +4%
GP
47
Guardian Partners
Canada
$758K +$874K +34,800 New
Barclays
48
Barclays
United Kingdom
$755K +$361K +14,375 +65%
DP
49
DDD Partners
Washington
$742K +$183K +7,294 +26%
FAIM
50
Financial Advocates Investment Management
Washington
$724K +$877K +34,896 New

ARKG Hedge Fund Activity: Q1 2025 in Review

215 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q1 2025, worth a combined $482M — down 16% from $575M a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of ARKG and 24 opened new positions — a net loss of 18 holders — while 56 trimmed existing stakes and 54 added.

The largest buyer was BNP Paribas Financial Markets, adding an estimated $31.5M. The largest seller was Bank of America, cutting an estimated $39.6M.

  • 215 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q1 2025, down from 239 in Q4 2024.
  • Funds reported $482M of ARK Genomic Revolution ETF stock for Q1 2025, down 16% quarter-over-quarter.
  • 24 funds opened new ARK Genomic Revolution ETF positions in Q1 2025 and 42 closed out, a net change of -18 holders.
  • The largest ARK Genomic Revolution ETF buyer in Q1 2025 was BNP Paribas Financial Markets, an estimated $31.5M added.
  • The largest ARK Genomic Revolution ETF seller in Q1 2025 was Bank of America, an estimated $39.6M sold.

Based on aggregated 13F filings for Q1 2025.